Does Health Insurance Cover Testosterone Replacement Therapy? (2026 Guide)

Health insurance does cover testosterone replacement therapy for most Americans diagnosed with hypogonadism, but whether your plan pays depends on three specific things your doctor controls: your lab results, your documented symptoms, and the formulation of testosterone prescribed.

If you’ve received results showing low testosterone and your doctor has recommended TRT, understanding your coverage options before filling that first prescription can save you hundreds of dollars a month. Testosterone replacement therapy (TRT) is a medical treatment that restores testosterone to clinically normal levels in men whose bodies fail to produce adequate amounts on their own. A physician prescribes it to treat hypogonadism, a documented hormonal condition confirmed through blood testing and clinical symptoms. Insurance classifies TRT as medically necessary only when it treats a diagnosed deficiency, not age-related testosterone decline or performance enhancement. This guide covers what each major insurer requires for approval, how different TRT formulations affect your coverage, and the exact steps for getting your plan to pay.

When Does Health Insurance Cover Testosterone Replacement Therapy?

The phrase “medically necessary” is the gate every TRT insurance claim must pass through. Most insurers define medical necessity using four core criteria.

Two separate morning blood draws on different days: Insurance covers testosterone replacement therapy when your levels are confirmed below the clinical threshold, typically 300 ng/dL, on two early-morning draws taken on separate days. A single test is almost never sufficient. Evening tests are routinely rejected because testosterone levels shift significantly throughout the day. The two-draw rule eliminates false readings caused by temporary factors like illness, acute stress, or disrupted sleep.

A formal diagnosis with the correct code: Your doctor must assign ICD-10 code E29.1 for hypogonadism. Vague chart language like “low T” or “hormone imbalance” is not sufficient. The specific diagnosis code must appear in your medical record and on the prior authorization request your doctor submits.

Documented symptoms in your chart: Lab numbers alone rarely win approval. Insurers look for clinical symptoms noted in your record: fatigue, decreased libido, erectile dysfunction, loss of muscle mass, or mood changes. These must be documented at the time of diagnosis, not added later.

Prior authorization from your doctor: Nearly every major plan requires your doctor to submit a formal prior authorization before the prescription is filled. The submission includes both lab results, the diagnosis code, your symptom history, and often a letter of medical necessity explaining why TRT is the appropriate treatment. Does insurance pay for testosterone replacement therapy when you miss one of these criteria? Generally, no. A single blood draw, borderline levels without symptoms, or undocumented clinical history are the three most common causes of denial. The good news: all three are correctable before you submit.

Does Blue Cross Blue Shield Cover Testosterone Replacement Therapy?

Blue Cross Blue Shield covers testosterone replacement therapy when it meets medical necessity criteria, but because BCBS operates as a federation of independent state-based plans, the specific requirements and formulary tiers vary by location. Most BCBS state plans follow a shared medical policy framework. Blue Cross Blue Shield of Minnesota, for example, requires males to have serum testosterone below the normal range on at least two separate morning draws before TRT is considered medically necessary.

The same policy applies step therapy to subcutaneous pellets (Testopel): oral, topical, or intramuscular testosterone must have been tried and found ineffective or not tolerated before a pellet implant will be approved. This step therapy requirement is common across BCBS plans nationally. Does Blue Cross cover testosterone replacement therapy in a state different from Minnesota? The criteria are similar across most state plans, but the specific threshold levels and covered formulations differ. BCBS of Texas and several other state plans publish their testosterone coverage criteria and acceptable CPT codes directly on their provider portals.

What most BCBS plans cover: Generic testosterone cypionate injections (Tier 1 or 2), testosterone enanthate injections, and topical gels when prior authorization is approved.

What requires step therapy or is commonly excluded: Testopel pellets, branded gels (AndroGel, Vogelxo), nasal testosterone (Natesto), and newer oral formulations (Jatenzo, Tlando).

If you carry a BCBS plan, your most direct next step is pulling your state-specific BCBS formulary, which lists covered testosterone formulations and the tier that determines your copay. Your doctor’s office can request this or help you identify the right plan document.

Does United Healthcare Cover Testosterone Replacement Therapy?

United Healthcare covers testosterone replacement therapy for diagnosed hypogonadism, including both primary hypogonadism (testicular failure) and hypogonadotropic hypogonadism (pituitary or hypothalamic dysfunction). UHC’s commercial medical policy specifies that injectable testosterone and Testopel are considered medically necessary when documentation confirms the required criteria are met.

One requirement that distinguishes UHC from some other carriers: the plan expects the underlying cause of low testosterone to be evaluated and noted in your record. If your low testosterone appears secondary to a reversible condition such as obesity, obstructive sleep apnea, or a medication side effect, UHC may expect documentation that those conditions are being addressed or are non-reversible before approving long-term TRT. If your doctor suspects a secondary cause, having that evaluation documented before the PA is submitted removes a common denial trigger.

Prior authorization is required for all testosterone formulations under UHC, and step therapy applies to branded or non-injectable options. Generic testosterone cypionate injections are the most reliably approved formulation under UHC commercial plans. For UHC Medicaid-managed plans (Community Plan), criteria are set by each state and can differ substantially from commercial policies.

Does Medicaid Cover Testosterone Replacement Therapy?

Medicaid coverage for testosterone replacement therapy is the most variable of any insurance type because each state administers its own Medicaid program with distinct formularies and prior authorization rules. States that have expanded Medicaid under the ACA often include TRT for diagnosed hypogonadism when the documentation is complete. Others restrict coverage to specific formulations, require additional prior authorization steps, or exclude TRT from the formulary altogether. What all state Medicaid programs share: you need a formal diagnosis from a Medicaid-enrolled provider, two qualifying blood draws, and in most cases prior authorization.

Does Medicaid cover testosterone replacement therapy for transgender individuals? Most states with expanded Medicaid do include hormone therapy for gender dysphoria, though the documentation requirements and approval process differ from hypogonadism-based coverage. If you’re uncertain whether your state’s Medicaid program covers TRT, call your state Medicaid office directly or ask your prescribing physician to check your state’s preferred drug list before submitting a prescription. Verifying coverage before submission avoids a denial that takes weeks to appeal.

Does Medicare Cover Testosterone Replacement Therapy?

Medicare covers TRT through two different parts of the program, and which part applies depends on how you receive the therapy.

Medicare Part B

covers testosterone when a medical professional administers it in an outpatient clinical setting. If you receive testosterone injections at your doctor’s office or a clinic, Part B pays 80% of the Medicare-approved cost after your annual deductible. Your Medigap supplement, if you carry one, typically covers the remaining 20%.

Medicare Part D

covers self-administered testosterone, including take-home injectable vials, topical gels, and patches. Coverage and out-of-pocket cost depend on which Part D plan you carry and the tier your specific formulation falls under in that plan’s formulary. A significant 2026 development: Medicare Advantage plans are increasingly applying evidence-based criteria tools, specifically InterQual guidelines, to TRT prior authorization reviews. This means some Medicare Advantage plans have tightened documentation requirements compared to previous years. One financial benefit: Medicare Part D now caps out-of-pocket drug costs at $2,000 annually beginning in 2026, which meaningfully limits total exposure for patients on branded or specialty testosterone formulations.

How the Type of TRT Affects What Insurance Pays

The formulation your doctor prescribes has a direct impact on whether insurance covers it and at what cost tier. This table reflects typical coverage patterns across major commercial and government plans.

TRT Formulation	Typical Coverage	Formulary Tier	Key Note
Testosterone cypionate injections (generic)	Most commonly covered	Tier 1 or 2	Lowest copay; baseline for step therapy
Testosterone enanthate injections (generic)	Commonly covered	Tier 1 or 2	Generic available; equivalent to cypionate
Topical gels (generic)	Usually covered	Tier 2 or 3	Higher copay than injections
Branded gels (AndroGel, Vogelxo)	Covered with step therapy	Tier 3 or 4	Must fail generic first
Testosterone patches	Covered, varies by plan	Tier 2 or 3	Moderate copay
Testopel pellets (subcutaneous)	Lowest coverage rate	Tier 3 or 4	Step therapy required; PA always needed
Oral testosterone (Jatenzo, Tlando)	Often not covered	Tier 4 or non-formulary	Newest agents; step therapy through injectables required
Nasal testosterone (Natesto)	Rarely covered	Non-formulary	Hardest to get approved across all plan types

Generic testosterone cypionate by injection is the most reliably covered formulation across every major carrier. Step therapy doesn’t mean injections are your only option permanently. Starting with generic injections gets you covered faster and creates documented treatment history that can support a later request for a different formulation.

How to Get Insurance to Pay for TRT: Step by Step

Consider a 41-year-old high school teacher who went to his primary care physician complaining of persistent fatigue, low libido, and noticeable muscle loss despite consistent workouts. His doctor ordered a morning testosterone panel. The first result came back at 267 ng/dL on a Tuesday. His doctor ordered a second draw the following week: 251 ng/dL. With two qualifying morning draws below 300 ng/dL, formal documentation of his symptoms across two visit notes, and a hypogonadism diagnosis entered as ICD-10 E29.1, his doctor submitted a prior authorization to his Blue Cross Blue Shield plan. Twelve days later, approval arrived. His monthly out-of-pocket cost for generic testosterone cypionate: $18.

That process is repeatable. Here are the specific steps:

Step 1: Schedule two early-morning testosterone draws on separate days: Both tests should be drawn between 7 a.m. and 10 a.m. when testosterone peaks. Both results need to fall below your insurer’s threshold, most commonly 300 ng/dL, to satisfy the dual-draw requirement.

Step 2: Document every symptom with your doctor at each visit: Fatigue, low sex drive, erectile dysfunction, mood changes, muscle loss, and increased body fat are all clinically relevant. If a symptom isn’t noted in your chart, it doesn’t exist for the purposes of the prior authorization. Bring a written symptom log to your appointment and ask your doctor to note specific symptoms in that visit’s record.

Step 3: Confirm your diagnosis code before PA submission: Ask your doctor to formally document hypogonadism using ICD-10 E29.1. This is the accepted code for the condition most insurers recognize for TRT coverage.

Step 4: Have your doctor submit the prior authorization: Your doctor’s office handles PA submission directly with the insurer. The request should include both lab results, the ICD-10 code, your documented symptom history, and a letter of medical necessity that explains why TRT is clinically appropriate for your case.

Step 5: Request generic testosterone cypionate as your initial formulation: If your preferred formulation is not on formulary or requires step therapy, starting with generic injections secures coverage faster. You can request a formulary exception or alternate formulation after your diagnosis and initial treatment are documented.

Step 6: Verify lab recency before submission: Some insurers reject blood draws older than six months. If your initial tests are aging, order fresh panels before your doctor submits the prior authorization.

What to Do When Insurance Denies Your TRT Claim

A denial is not a final answer. Most TRT denials are overturned when patients submit a properly documented appeal, and there are four escalating options available to you.

Step 1: Request the denial reason in writing: Insurers are required to provide a written explanation. The three most common denial reasons for TRT: a single blood draw instead of two, missing symptom documentation in the medical record, or a formulation that isn’t on formulary. Knowing the specific reason tells you exactly what to fix.

Step 2: Request a peer-to-peer review: Your doctor can call the insurer’s medical director directly to discuss your case. This physician-to-physician conversation frequently resolves denials that appear unresolvable on paper, particularly when the denial is based on documentation gaps rather than a genuine coverage exclusion.

Step 3: Submit a formal internal appeal: Include both lab results, the ICD-10 diagnosis code, your documented symptom history, and a letter of medical necessity from your doctor that addresses the denial reason directly. The letter of medical necessity is the most important document in any appeal. It should reference the insurer’s specific stated reason for denial and provide clinical justification for overturning it.

Step 4: Request an external independent review: Under the ACA, if your internal appeal is denied, you have the legal right to request a review by an independent third-party medical reviewer. Insurers are required to comply with this process and to abide by the external reviewer’s decision.

Step 5: File a complaint with your state insurance department: If coverage is denied through all internal channels and you believe your plan is violating state or federal coverage law, your state’s insurance commissioner handles formal complaints and has authority to investigate and intervene.

How Much Does TRT Cost With Insurance?

With an approved prior authorization, most patients pay between $10 and $30 per month in copayments for generic testosterone cypionate or enanthate injections. That reflects standard Tier 1 or Tier 2 copay structures on employer-sponsored and ACA marketplace plans. Gels and patches carry higher copays even with coverage, typically $50 to $150 per month depending on whether the product is generic or branded and which formulary tier your plan assigns it. Testopel pellets, when covered, usually run $100 to $200 per insertion procedure after plan cost-sharing.

Without insurance, generic testosterone cypionate averages $30 to $80 per month through standard retail pharmacies, making it one of the more manageable specialty therapies even outside plan coverage. Branded formulations and newer oral medications run $200 to $600 per month without coverage, which is the primary reason step therapy requirements exist. If coverage is unavailable or the administrative process isn’t worth pursuing for your situation, direct-pay TRT clinics offer all-inclusive monthly programs (medication, lab monitoring, and physician oversight) at flat rates that are often comparable to out-of-pocket branded formulation costs. Discount programs like GoodRx can reduce generic testosterone cypionate to $25 to $45 per month at major pharmacy chains.

Frequently Asked Questions About TRT and Health Insurance

What testosterone level does insurance require to cover TRT?

Most major insurers require testosterone levels below 300 ng/dL on two separate early-morning blood draws. Some plans use a threshold of 250 ng/dL; others go up to 350 ng/dL depending on their clinical coverage policy. Ask your doctor to pull your specific insurer’s prior authorization criteria to confirm the threshold before your draws are scheduled.

Does Blue Cross Blue Shield cover testosterone replacement therapy?

Yes. BCBS plans generally cover TRT when medical necessity is documented, but specific criteria and covered formulations vary by state. Most state BCBS plans require two morning draws below normal range, ICD-10 E29.1 diagnosis, and prior authorization. Pellets require step therapy through injections or topicals first. Check your state BCBS formulary for your plan’s exact terms.

Does United Healthcare cover testosterone replacement therapy?

Yes, for diagnosed hypogonadism. UHC commercial plans cover injectable testosterone and Testopel when documentation is complete. UHC also requires evaluation of reversible causes before approving long-term TRT. Prior authorization is required for all formulations. UHC Medicaid community plans follow state-specific criteria.

Does Medicaid cover testosterone replacement therapy?

It depends on your state. Some states cover TRT for hypogonadism with prior authorization; others exclude it from the formulary. Most states with expanded Medicaid also cover testosterone for gender-affirming care. Call your state Medicaid office or ask your prescribing provider to check your state’s preferred drug list.

Does insurance cover testosterone pellets?

Testosterone pellets (Testopel) have the lowest coverage rate of any TRT formulation. Most plans require step therapy: you must first try and document failure on injectable or topical testosterone before a pellet implant will be approved. Prior authorization is always required, and some plans exclude pellets entirely.

Can I use an HSA or FSA to pay for TRT?

Yes. Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) cover TRT prescriptions, associated lab work, and related office visits when testosterone therapy is prescribed for a documented medical diagnosis. This applies whether or not your insurance plan covers TRT separately.

Does insurance cover TRT for women?

Less commonly than for men. Most major insurers do not have a defined clinical coverage policy for female testosterone therapy. Claims are more likely to be denied or require extensive documentation and a compelling clinical justification. Some plans do cover it under specific off-label indications. Expect the PA process to take longer and require more physician documentation.

What happens if insurance denies my TRT claim?

Request the denial reason in writing, then ask your doctor to initiate a peer-to-peer review with the insurer’s medical director. Most denials are correctable through better documentation or that physician conversation. If that fails, file a formal internal appeal with complete supporting records. If the internal appeal is denied, you have the right to an external independent review under the ACA.

Is TRT covered under ACA marketplace plans?

ACA-compliant marketplace plans cover TRT under the prescription drug benefit when medical necessity is documented. TRT is classified as a specialty medication, not preventive care, so it is not automatically covered without diagnosis documentation. Coverage terms and copay amounts vary by metal tier (Bronze, Silver, Gold, Platinum).

How long does TRT prior authorization take?

Most insurers are required to respond to standard PA requests within 14 calendar days. Urgent requests must be processed within 72 hours. In practice, many prior authorizations for TRT resolve within 5 to 10 business days when documentation is complete. Incomplete submissions, particularly those missing the second blood draw result or symptom documentation, are the most common cause of delays.

If you have two qualifying morning testosterone draws and documented symptoms on file, call your primary care doctor or a urologist this week and request a formal hypogonadism diagnosis with prior authorization submission. That one conversation is the difference between paying out of pocket and paying your plan’s copay.